Epidemiologic and Clinical Characteristics of Cardiomyopathies in Japan. Results From Nationwide Surveys.-Reference-Cited by-同舟云学术

Epidemiologic and Clinical Characteristics of Cardiomyopathies in Japan. Results From Nationwide Surveys.

Published:2002 Issue:4 Volume:66 Page:323-336
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Matsumori Akira¹,Furukawa Yutaka¹,Hasegawa Koji¹,Sato Yukihito¹,Nakagawa Hideaki²,Morikawa Yuko²,Miura Katsuyuki²,Ohno Yoshiyuki³,Tamakoshi Akiko³,Inaba Yutaka⁴,Sasayama Shigetake¹,Co-research workers ⁵

Affiliation:

1. Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine

2. Department of Public Health, Kanazawa Medical University

3. Department of Preventive Medicine/Biostatistics and Medical Decision Making, Nagoya University Graduate School of Medicine

4. Department of Epidemiology and Environmental Health, Juntendo University School of Medicine

5. Co-research workers are listed in Appendix.

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

http://www.jstage.jst.go.jp/article/circj/66/4/66_4_323/_pdf

Reference38 articles.

1. 1. 1999 Heart and Stroke Statistical Update. Dallas, TX: American Heart Association; 1998.

2. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies

3. Prevalence and characteristics of dystrophin defects in adult male patients with dilated cardiomyopathy

4. Mutations in the Genes for Cardiac Troponin T and α-Tropomyosin in Hypertrophic Cardiomyopathy

5. Molecular and Immune Mechanisms in the Pathogenesis of Cardiomyopathy

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Registro Mexicano de Miocardiopatías: datos basales, estrategias diagnósticas y abordajes terapéuticos en Mexico;Archivos de Cardiología de México;2024-07-29

2. Impact of cannabidiol on myocardial recovery in patients with acute myocarditis: Rationale & design of the ARCHER trial;ESC Heart Failure;2024-06-27

3. JCS/JHRS 2022 Guideline on Diagnosis and Risk Assessment of Arrhythmia;Journal of Arrhythmia;2024-06-12

4. Prostaglandin E2 and myocarditis; friend or foe?;Biochemical Pharmacology;2023-11

5. JCS/JHRS 2022 Guideline on Diagnosis and Risk Assessment of Arrhythmia;Circulation Journal;2023-09-11